Dr. Benalfew Tesfaye Legesse, MD

Dr. Legesse practices at HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare.

Dr. Legesse's NPI, 1376767988, was assigned on April 13, 2007. Dr. Legesse graduated from Addis Ababa University Faculty of Medicine in 1999. Dr. Legesse holds Florida license ME157729.

Dr. Legesse's primary practice is HCA Florida Memorial Hospital, at 3625 University Blvd S, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 702-6111.

Dr. Legesse's primary practice is HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare. Dr. Legesse is also affiliated with HCA Florida Orange Park Hospital. The medical group on file is HCA Florida Jacksonville Primary Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Legesse practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Legesse's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Legesse is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Legesse's licenses on file in 3 states: Florida, Massachusetts and West Virginia.

Dmand AI lists anxiety, bipolar disorder, dementia, depression, non-alzheimer's dementia (chronic), psychoses and schizophrenia among the conditions Dr. Legesse treats.

CMS data shows 677 Medicare services from Dr. Legesse across 5 procedure codes in 2024, for 132 Medicare patients. Medicare paid $48,357 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 132 Medicare patients who saw Dr. Legesse in 2024. The largest group is under 65, with 49 patients. 75% of them have anxiety, and 75% have depression. 46% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Legesse's median patient age at 56, with 58% women.

In 2024, Dr. Legesse wrote 476 Medicare Part D claims for 89 patients. 96% of them were for generic drugs. CMS names the drug for 230 of them, across 12 drugs with 11 or more claims each, at $1,048 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Legesse for performance year 2024, reported as part of a group. Dr. Legesse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Legesse, published from 2007 to 2017. 2017 was the busiest year, with 2. Dr. Legesse's most frequent co-authors are Bruce Heimburger Price, MD, Baktash Babadi, MD, PhD and Brent Peter Forester, MD.

Dmand AI links Dr. Legesse to 1 clinical trial. Conditions studied include Alzheimer Disease and Tauopathies. Open Payments lists research payments to Dr. Legesse that name 1 trial.

CMS Open Payments shows 4 general payments to Dr. Legesse from 3 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $117. It also lists 1 research payment totaling $149 in 2016, naming 1 clinical trial.

Dr. Legesse graduated from Addis Ababa University Faculty of Medicine in 1999.

Dr. Legesse is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.